Science / Turmeric

Jäger et al. · 2014 — Curcumin Study — Professional

High-Potency Turmeric Extract · NPN 80143038. Product facts and study findings are identified separately.

Jäger et al. · 2014 · Branded Ingredient Evidence — external comparators

Evidence Type: Randomized double-blind crossover human pharmacokinetic study.
Studied Material / Formulation: Phytosome, volatile-oil and carrier-based formulations versus an unformulated mixture.
Population: 12 healthy volunteers completed four treatments.
Dose: 376 mg total curcuminoids in formulated arms; 1,800 mg in the reference arm.
Duration: 12-hour sampling per treatment; at least 7-day washout.
Main Findings: Blood appearance differed between formulations.
Limitations: Small, acute study; hydrolysed plasma analysis; unequal doses; no clinical endpoint. Funded by OmniActive.
Product Relevance: Demonstrates why formulation matters. None is verified as this product’s ingredient; no absorption ratio transfers.
DR.MORGAN finished product studied: NO

This study was not conducted on the finished DR.MORGAN product.

Source review: Original publication reviewed; formulation-specific interpretation. DOI 10.1186/1475-2891-13-11. PMID 24461029.

Licensed product information